Company Filing History:
Years Active: 2022
Title: Innovator Helga Helgadottir: Pioneering Thermostable Pharmaceutical Formulations
Introduction: Helga Helgadottir, an inventor based in Akranes, Iceland, has made significant contributions to the field of pharmaceuticals with her innovative work. She holds a patent for a novel thermostable formulation aimed at administering biologically active substances, demonstrating her expertise and commitment to scientific advancement.
Latest Patents: Helgadottir's patented creation, titled "Thermostable formulation of biologically active substances," focuses on delivering a therapeutically effective amount of an antimicrobially active monoglyceride to mammals. The formulation is designed to be administered in volumes ranging from 1 to 5000 μL to various surfaces, including nasal, ocular, and dermal areas. This innovative composition utilizes methoxypolyethylene glycol (mPEG) and polyoxyethylene glycol (PEG)-fatty acid mono- or diglycerides, ensuring that the formulation maintains thermostability across a temperature spectrum, facilitating its therapeutic effectiveness.
Career Highlights: Helga Helgadottir currently works at Capretto Ehf., where she continues to develop and refine her pharmaceutical formulations. Her dedication to research and development in biologically active substances has positioned her as a notable inventor in her field.
Collaborations: Throughout her career, Helgadottir has collaborated with talented coworkers, including Sveinbjorn Gizurarson and Thordis Kristmundsdottir. These partnerships have fostered a creative environment that encourages innovation and further advances in the pharmaceutical sector.
Conclusion: Helga Helgadottir's invention of a thermostable formulation of biologically active substances exemplifies her impactful role as an inventor. With her work at Capretto Ehf. and collaborations with skilled colleagues, she continues to contribute to advancements in pharmaceutical sciences, aiming to improve therapeutic outcomes for mammals through her innovative formulations.